- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05197101
To Evaluate the Efficacy and Safety of Balloon Catheter Combined With Oxytocin Induction in Nulliparous Women With Estimated Fetal Weight ≥3500g at 39-40 Weeks of Gestation
January 17, 2022 updated by: The First Affiliated Hospital with Nanjing Medical University
To Evaluate the Efficacy and Safety of Balloon Catheter Combined With Oxytocin Induction in Nulliparous Women With Estimated Fetal Weight ≥3500g at 39-40 Weeks of Gestation: a Randomized, Controlled, Observational Study
This study is a randomized, controlled, observational study.
150 nulliparous women with estimated fetal weight ≥3500g at 39-40 weeks of gestation will be enrolled as subjects in the two groups is 1:1.
In the experimental group, vaginal examination will be performed at 39 to 40 weeks to assess cervical conditions.
If the bishop score <6, the balloon catheter combined with oxytocin induction will be planned at 40 weeks ±3 days.
In the control group, one week to 41 weeks ±3 days will be expected.
Vaginal examination will be performed again to evaluate cervical conditions.
If the bishop score <6 points, and balloon catheter combined with oxytocin induction will be performed.
After 96h, their final delivery mode will be recorded.
In the following 42 days postpartum, their complications and the neonatal outcome will be followed up.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ziyan Jiang, doctor
- Phone Number: 13512534017
- Email: zyjiangchm@163.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria: singleton head position pregnancy, negative Down's screening and /or NIPT screening, no malformation was found, with slight/without pregnancy complications -
Exclusion Criteria:twin or multiple pregnancy, scar uterus, with contraindications to vaginal delivery, estimated fetal weight >4500g
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: nulliparous women with estimated fetal weight ≥3500g at 39-40 weeks of gestation
|
Balloon catheter for 12 hours and oxytocin for up to 3days.If failed , they will be treated ceacrean.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
vaginal birth rate
Time Frame: 24 hours
|
After spontaneous labor for up tp 24 hous, the mode of delivery will be konwn and recorded.
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 17, 2022
Primary Completion (Anticipated)
January 17, 2023
Study Completion (Anticipated)
March 17, 2023
Study Registration Dates
First Submitted
January 17, 2022
First Submitted That Met QC Criteria
January 17, 2022
First Posted (Actual)
January 19, 2022
Study Record Updates
Last Update Posted (Actual)
January 19, 2022
Last Update Submitted That Met QC Criteria
January 17, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PIIM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Macrosomia, Fetal
-
The University of Texas Health Science Center,...WithdrawnMacrosomia, Fetal | Retardation, Fetal Growth
-
The University of Texas Health Science Center,...Harris Health System, Lyndon B Johnson Hospital obstetrics and gynecology...WithdrawnLabor Induction | Macrosomia, Fetal
-
University of Modena and Reggio EmiliaTerminatedMacrosomia, Fetal | Large for Gestational Age BabyItaly
-
Peking University First HospitalCompletedDiabetes | Gestational Diabetes | Macrosomia, Fetal
-
The University of Texas Health Science Center,...Recruiting
-
Cairo UniversityRecruitingGestational Diabetes | IUGR | Pre-Gestational Diabetes | Macrosomia, FetalEgypt
-
Tufts Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingObesity | Lifestyle-related Condition | Macrosomia, FetalUnited States
-
Hospices Civils de LyonActive, not recruitingBirth Weight | Macrosomia, FetalFrance
-
CHU de ReimsUnknown
-
Assiut UniversityNot yet recruitingShoulder Dystocia | Macrosomia, Fetal | Large for Gestational Age
Clinical Trials on balloon catheter combined with oxytocin induction
-
Jena University HospitalCompleted
-
University of Southern CaliforniaUnknownPregnancy | Labor; Forced or Induced, Affecting Fetus or NewbornUnited States
-
Hillel Yaffe Medical CenterUnknownCervix; Insufficient Dilatation in LaborIsrael
-
Western Galilee Hospital-NahariyaRecruiting
-
Western Galilee Hospital-NahariyaCompletedPrevious Cesarean Section | Induction of Labor | Hormonal ChangesIsrael
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Multiple Sclerosis Society of...Completed
-
Western Galilee Hospital-NahariyaCompletedCesarean | Endometritis | Induction of LaborIsrael
-
University of California, San FranciscoCompletedInduction of LaborUnited States
-
Soroka University Medical CenterUnknownPrelabor Rupture of Membranes | Previous; Cesarean Section, Cicatricial, Complicating Pregnancy or Childbirth, Affecting Fetus or NewbornIsrael
-
Tel-Aviv Sourasky Medical CenterUnknownFetal Growth Retardation | Induction of Labor Affected Fetus / NewbornIsrael